Lydia Bergamasco
About Lydia Bergamasco
Independent director of IROH (post–business combination CN Healthy Food Tech Group Corp.), appointed at Closing reported October 6, 2025. Background spans digital product/informatics at Memorial Sloan Kettering and nutrition coaching; education includes a B.A. in Economics (SUNY Old Westbury) and M.S. in Exercise Science & Health (Liberty University) .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Rallye Acura | Client Care Representative & Administrative Assistant | 2013–2014 | Client service/operations |
| Memorial Sloan Kettering Cancer Center | Various roles; Digital Product & Informatics Project Coordinator (current) | 2015–present; current role since 2021 | Digital product, informatics project coordination |
| New York Sports Judo Club | Nutritionist | Jul 2022–present | Athlete nutrition support |
External Roles
No public-company board roles disclosed; career roles at MSK and NY Sports Judo Club are operating/functional positions, not directorships .
Board Governance
- Independence: Board determined all directors except Zhenjun Jiang and Pan Hu are independent; Lydia is independent. Independent directors will have regularly scheduled meetings (executive sessions) .
- Board structure: One class of directors with annual elections and one-year terms (no classified board) .
- Committee assignments post-closing:
- Audit Committee: John L. Suprock, Lydia Bergamasco, Jingyu Huang (chair); all independent and “financially literate”; Huang designated audit committee financial expert .
- Compensation Committee: John L. Suprock (chair), Jingyu Huang; both independent .
- Nominating & Corporate Governance Committee: Donghai Li and Lydia Bergamasco (chair) .
Fixed Compensation
- CFI (pre-combination target) did not compensate its directors for board service .
- New CFI/CN Healthy: Company stated it had not yet determined whether and to what extent directors will be paid for their service post-combination .
Performance Compensation
No director equity awards, options, or performance-based incentives disclosed; CFI reported no stock option plans or outstanding equity awards for directors, and no director compensation. New CFI has not finalized director compensation policy post-closing .
Other Directorships & Interlocks
- No other public-company directorships, committee roles, or interlocks disclosed for Lydia. Her disclosed experience is in health, nutrition, and digital product coordination; no reported ties to IROH’s sponsors, customers, suppliers, or competitors .
Expertise & Qualifications
- Education: B.A. Economics (SUNY Old Westbury); M.S. Exercise Science & Health (Liberty University) .
- Technical/functional: Digital product and informatics project coordination; nutrition; qualifies as “financially literate” for Audit Committee membership under Nasdaq standards (as part of committee composition) .
Equity Ownership
No beneficial ownership, vested/unvested share breakdown, options, or pledging disclosures for Lydia in available filings post-closing; CFI indicated no director compensation and no equity awards, and New CFI has not finalized director compensation .
Governance Assessment
- Strengths: Independent director; chairs Nominating & Corporate Governance Committee (key role in board refresh, independence, and evaluation); member of Audit Committee, meeting Nasdaq “financially literate” criteria. Independent directors will hold scheduled executive sessions, supporting oversight quality .
- Gaps/Risks: Director compensation framework post-combination not determined, which reduces clarity on alignment and incentives; no disclosure of director equity ownership guidelines or holdings; limited industry-specific governance experience disclosed (health/nutrition background) may require onboarding to SPAC-deSPAC public-company controls and U.S. GAAP oversight .
- Overall signal: Committee leadership and independence support investor confidence; lack of defined director pay/ownership policy is a governance uncertainty to monitor in upcoming proxy/8-K updates .